Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combined formula for treating inflammatory bowel disease

An inflammatory bowel disease and formula technology, applied in the field of combination formula of traditional Chinese medicinal materials and amino acids, can solve problems such as unsatisfactory effect and large side effects, and achieve the effect of prolonging human lifespan, good therapeutic effect, and enhancing blood supply and oxygen supply.

Inactive Publication Date: 2016-03-16
何松庆
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] 1. 0.5 grams of ganoderma lucidum, 0.6 grams of salvia miltiorrhiza, and 0.5 grams of threonine are made into chewing agents, 2 to 4 times a day.

[0026] 2. 0.25 grams of ganoderma lucidum, 0.3 grams of salvia miltiorrhiza, and 0.25 grams of threonine are made into chewing agents, 2 to 4 times a day.

[0027] 3. 0.5 grams of Ganoderma lucidum, 0.6 grams of Salvia miltiorrhiza, and 0.5 grams of threonine are made into medicines, 2 to 4 times a day.

[0028] 4. 0.25 grams of Ganoderma lucidum, 0.3 grams of Salvia miltiorrhiza, and 0.25 grams of threonine are made into medicines, 2 to 4 times a day.

[0029] 5. 5 grams of Ganoderma lucidum, 6 grams of Salvia miltiorrhiza, and 0.5 grams of threonine are made into oral preparations, 2 to 4 times a day.

[0030] 6. 2.5 grams of Ganoderma lucidum, 3 grams of Salvia miltiorrhiza, and 0.25 grams of threonine are made into oral preparations, 2 to 4 times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a combined formula for treating inflammatory bowel disease, and belongs to the field of medicine. The combined formula is a formula with the principle of reinforcing intestinal epithelia goblet cells, building a normal intestinal surface mucous layer barrier, preventing intestinal antigens from being close to, making contact with, adhering to and going into intestinal wall tissues, so as to block the occurrence of abnormal immune response and inflammation. Ganoderma lucidum and salvia miltiorrhiza have the efficacies of enhancing human body blood supply and oxygen supply; threonine is a constituent part of mucoproteins and is also a human body essential amino acid. The formula provides nutrients, oxygen and raw materials for generation, updating and repairing of the goblet cells and for goblet cell secreting of the mucoproteins to construct the intestinal surface mucous layer barrier. The three-in-one formula has obvious effects on building the human body normal intestinal surface mucus layer barrier, terminating inflammation and repairing intestinal tissues, and is an effective formula for treating inflammatory bowel disease.

Description

technical field [0001] The invention relates to a combined formula of Chinese medicinal materials and amino acids for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immune system and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P1/00A61K31/198
CPCA61K36/074A61K9/0056A61K31/198A61K36/537
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com